A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
Phase 1/2
55
about 5 years
18+
Female only
2 sites in NJ, NY
About this study
Researchers are testing whether pre-operative mpMRI with additional sequences can improve surgical outcomes by providing more accurate information about the extent and acidity of the tumor than standard MRI. The trial also tests if using the fluorescent imaging agent pHLIP ICG during surgery, along with NIRF imaging, allows surgeons to see cancer cells in the tumor and nearby tissues more clearly and remove them completely.
Based on ClinicalTrials.gov records.
What participants do
- 1.Undergo pHLIP® ICG NIRF imaging
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Dose-limiting toxicity (DLT)
imaging
diagnostic
Oncology